Table 1 Characteristics of the included studies
First author | Year | LncRNA | Expression | Sample size (high/low) | Cut-off value | PT | Survival | Survival analysis | HR availability | NOS score |
|---|---|---|---|---|---|---|---|---|---|---|
Mingzhe Ma | 2015 | LET | Downregulated | 128 (47/81) | Median | No | OS, DFS | U, M | Text | 8 |
Mingzhe Ma | 2016 | GCASPC | Downregulated | 89 (45/44) | Median | No | OS, DFS | U, M | K–M curve | 8 |
Qiang Cai | 2016 | LINC00152 | Upregulated | 40 (23/17) | Fold change | No | NA | NA | NA | 6 |
Bo Liu | 2016 | MEG3 | Downregulated | 84 (42/42) | Median | No | OS | U | K–M curve | 7 |
ANRIL | Upregulated | 84 (42/42) | Median | No | OS | U | K–M curve | |||
Shouhua Wang | 2016 | MALAT1 | Upregulated | 30 (15/15) | Median | No | OS | U | K–M curve | 8 |
Shouhua Wang | 2016 | MINCR | Upregulated | 35 (18/17) | Median | No | OS | U | K–M curve | 8 |
Fei Ma | 2017 | AFAP1-AS1 | Upregulated | 40 (19/21) | Mean | No | OS | U | K–M curve | 6 |
Qiang Cai | 2017 | LINC00152 | Upregulated | 35 (18/17) | Median | No | OS | U | K–M curve | 6 |
Qiang Cai | 2017 | UCA1 | Upregulated | 45 (23/22) | Median | No | OS | U | K–M curve | 8 |
Xiangsong Wu | 2017 | PAGBC | Upregulated | 77 (38/39) | Median | No | OS | U | Text | 8 |
Xiaocai Wu | 2017 | Loc344887 | Upregulated | 22 (15/7) | NA | No | NA | NA | NA | 5 |
Shouhua Wang | 2017 | ROR | Upregulated | 30 (14/16) | Median | No | OS | U | K–M curve | 7 |
Longyang Jin | 2018 | MEG3 | Downregulated | 50 (24/26) | Mean | No | OS | U, M | Text | 8 |
Liang Yang | 2018 | HEGBC | Upregulated | 102 (51/51) | Median | No | OS | U | K–M curve | 8 |
Shouhua Wang | 2018 | H19 | Upregulated | 20 (12/8) | NA | No | NA | NA | NA | 6 |
Shouhua Wang | 2019 | H19 | Upregulated | 24 (13/11) | Median | No | OS | U | K–M curve | 6 |
Jianan Chen | 2019 | PVT1 | Upregulated | 66 (33/33) | NA | NA | OS | U, M | Text | 8 |